270 related articles for article (PubMed ID: 14562142)
21. Intracorporeal phenylephrine in the treatment of priapism.
Muruve N; Hosking DH
J Urol; 1996 Jan; 155(1):141-3. PubMed ID: 7490814
[TBL] [Abstract][Full Text] [Related]
22. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
Asuar Aydillo S
Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
[No Abstract] [Full Text] [Related]
23. [New treatments in erectile dysfunction].
Palma-Aguirre JA
Gac Med Mex; 1999; 135(6):663-8. PubMed ID: 10605271
[No Abstract] [Full Text] [Related]
24. Use of intraurethral alprostadil in patients not responding to sildenafil citrate.
Jaffe JS; Antell MR; Greenstein M; Ginsberg PC; Mydlo JH; Harkaway RC
Urology; 2004 May; 63(5):951-4. PubMed ID: 15134987
[TBL] [Abstract][Full Text] [Related]
25. [Complications of intracavernous pharmacologic infusion in impotence. Long-term results].
Pastorini S; Marino G; Cocimano V; Griffa D; Pugno E
Minerva Urol Nefrol; 1993 Sep; 45(3):109-12. PubMed ID: 8278876
[TBL] [Abstract][Full Text] [Related]
26. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction.
Hübler J; Szántó A; Könyves K
Int Urol Nephrol; 2003; 35(4):519-21. PubMed ID: 15198160
[TBL] [Abstract][Full Text] [Related]
27. Protease inhibitors, sexual dysfunction and Viagra.
Gilden D
GMHC Treat Issues; 1999 Mar; 13(3):12. PubMed ID: 11366202
[TBL] [Abstract][Full Text] [Related]
28. Evaluating erectile dysfunction: oral sildenafil versus intracavernosal injection of papaverine.
Viswaroop B; B A; Gopalakrishnan G
Natl Med J India; 2005; 18(6):299-301. PubMed ID: 16483029
[TBL] [Abstract][Full Text] [Related]
29. Erectile dysfunction: on the efficacy of a phosphodiesterase inhibitor with concurrent sex therapy.
Rosenstock HA; Axelrad SD
Asian J Androl; 1999 Dec; 1(4):207-10. PubMed ID: 11225896
[No Abstract] [Full Text] [Related]
30. Phosphodiesterase-5 inhibitors and migraine.
Evans RW; Kruuse C
Headache; 2004 Oct; 44(9):925-6. PubMed ID: 15447704
[No Abstract] [Full Text] [Related]
31. Acute myocardial infarction after the use of sildenafil.
Arora RR; Timoney M; Melilli L
N Engl J Med; 1999 Aug; 341(9):700. PubMed ID: 10475830
[No Abstract] [Full Text] [Related]
32. FDA updates labeling for erectile dysfunction drugs.
FDA Consum; 2005; 39(5):3. PubMed ID: 16419280
[No Abstract] [Full Text] [Related]
33. [No taboo for heart patients].
MMW Fortschr Med; 2002 Aug; 144(31-32):51. PubMed ID: 12422736
[No Abstract] [Full Text] [Related]
34. Erectile dysfunction.
Hagland M
Bus Health; 2000; 18(10 Suppl A):11-3. PubMed ID: 11146849
[No Abstract] [Full Text] [Related]
35. Non-arteritic anterior ischemic optic neuropathy, erectile dysfunction drugs, and amiodarone: is there a relationship?
Fraunfelder FW; Shults T
J Neuroophthalmol; 2006 Mar; 26(1):1-3. PubMed ID: 16518158
[No Abstract] [Full Text] [Related]
36. [Cytolytic acute hepatitis probably due to sildenafil (Viagra)].
Maroy B
Gastroenterol Clin Biol; 2003 May; 27(5):564-5. PubMed ID: 12843928
[No Abstract] [Full Text] [Related]
37. Comment: comparison of FDA reports of patient deaths associated with sildenafil and injectable alprostadil.
Strom BL
Ann Pharmacother; 2001 Sep; 35(9):1143. PubMed ID: 11573871
[No Abstract] [Full Text] [Related]
38. [Advances in application of sildenafil to erectile dysfunction].
Li Z; Wu ZM; Wang YX
Zhonghua Nan Ke Xue; 2005 Jun; 11(6):473-6. PubMed ID: 15999498
[TBL] [Abstract][Full Text] [Related]
39. [Erectile dysfunction in coronary heart disease. No fear about the blue pill].
MMW Fortschr Med; 2001 Jan; 143(3):54-6. PubMed ID: 11215348
[No Abstract] [Full Text] [Related]
40. Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs.
Kulmala RV; Tamella TL
Int J Impot Res; 1995 Jun; 7(2):131-6. PubMed ID: 7496442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
